AstraZeneca opened a new global strategic R&D center in Kendall Square in Cambridge, Massachusetts. AstraZeneca invested $1 billion to increase the number of employees in Massachusetts by more than 50%.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.